Fetal Bovine Serum Market: By Product, By Application, By End-User, and Geography

Fetal Bovine Serum Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Charcoal, Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products), By Application (Biopharmaceuticals, Cell Culture Media, Human and Animal Vaccine Production, Drug Discovery, Vaccine Production), By End-User (Biotechnology and Pharmaceutical Industries, Academic institutes, Research labs, Diagnostic labs, CROs, CMOs, IVF Centers, Others), and Region

Fetal Bovine Serum Market size was valued at US$ 1,285.6 million in 2023 and is expected to grow at a 6.1% CAGR from 2024 to 2030. Fetal bovine serum is a blood-derived product obtained from the blood of fetal bovine fetuses. It is rich in various growth factors, hormones, and other nutrients, making it an ideal supplement to promote the progress and proliferation of many types of animal cells. Factors such as the expansion of the biopharmaceutical industry in developing countries as well as established markets are expected to spur the demand for fetal bovine serum (FBS) in coming years.

Furthermore, increasing R&D activities and expenditure by key players for the introduction of new products in the market are some of the major factors driving the market growth. Moreover, the increasing application of fetal bovine serum in drug discovery, and vaccine production is leading to a rise in demand for fetal bovine serum products. Moreover, the pandemic led to a heightened demand for the development of vaccines to curb the spread of the virus and reduce its severe effects. Fetal bovine serum is extensively used in developing vaccines and therefore rise in demand for vaccine development had a direct impact on the market and led to an increase in sales of fetal bovine serum.

Moreover, the rising focus of the pharma industry to develop and introduce new drugs in the market due to the rising prevalence of acute and chronic diseases is also augmenting the growth of the market. However, the high cost of fetal bovine serum as well as the increasing preference of manufacturers to develop serum-free media is limiting the growth of the market. The efficacy of cellular reprogramming for induced pluripotent stem cells leads to the high demand for the product. The broader range of applications of the stem cell is likely to fuel the segmental growth, as it requires a fetal bovine serum cell line for tissue culture. Moreover, the advantages of FBS in serum cell culture, such as its ability for stem cell differentiation, morphology, cell growth and expansion, and clonal efficiency, are driving their adoption. Furthermore, there is a growing trend of adoption of technologically advanced stem cell lines, which pose capabilities, including steam-in-place (SIP) sterilization, filtration for sterility, and many others.

Fetal Bovine Serum Market Key Developments:

  • In April 2021, Thermo Fisher Scientific Inc. and PPD Inc. announced a definitive agreement under which Thermo Fisher will acquire PPD for US$ 17.4 billion.
  • In March 2021, Merck KgAA announced that it will expand a single-use assembly production unit at its Life Science Center in Molsheim, France, with a EUR 25 million investment.

Fetal Bovine Serum Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Fetal Bovine Serum Market Dynamics

The fetal bovine serum (FBS) market dynamics are driven by increasing demand from biopharmaceutical research and development, where FBS is crucial for cell culture applications. Growth in specialized FBS variants tailored for specific applications such as stem cell culture, vaccine production, and diagnostics gives an upper hand for FBS compared to other media available. Untapped potential in developing regions with expanding biotech and pharmaceutical sectors, customization, and specialty product options available in FBS are the main opportunities of this market. Challenges include ethical concerns over FBS sourcing and supply chain vulnerabilities. However, ongoing innovations in alternative cell culture supplements and regulatory advancements are shaping the market's future, emphasizing sustainability and quality assurance in FBS production and usage. Even though all these advancements are present, recent trends tell a different story increasing demand and shift to serum-free and defined media formulations and pressure to adopt sustainable practices in FBS production due to concerns over variability and ethical issues related to FBS.

Fetal Bovine Serum Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 1,285.6 million

Market CAGR

6.1%

By Product Type

  • Charcoal Stripped
  • Chromatographic
  • Dialyzed Fetal Bovine Serum
  • Exosome Depleted
  • Stem Cell
  • Other Products

By Application

  • Biopharmaceuticals
  • Cell Culture Media
  • Human and Animal Vaccine Production
  • Drug Discovery
  • Vaccine Production

By End User

  • Biotechnology and Pharmaceutical Industries
  • Academic institutes
  • Research labs
  • Diagnostic labs
  • CROs
  • CMOs
  • IVF Centers
  • Others

Key Features of the Report

  • The fetal bovine serum market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

The fetal bovine serum market was valued at US$ 1,285.6 million in 2023 and is expected to grow at a 6.1% CAGR from 2024 to 2030.

Thermo Fischer Scientific, Inc., Danaher Corporation, Merck KGaA, HiMedia Laboratories, and GE Healthcare are some of the major players operating in the Fetal Bovine Serum Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period.

North America accounts for the largest market share and is expected to be the primary market driver in the Fetal Bovine Serum market.

The high cost of fetal bovine serum as well as the increasing preference of manufacturers to develop serum-free media are expected to limit the growth of the Fetal Bovine Serum market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Fetal Bovine Serum Market Introduction 
2.1.Global Fetal Bovine Serum Market  - Taxonomy
2.2.Global Fetal Bovine Serum Market  - Definitions
2.2.1.Product Type 
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Fetal Bovine Serum Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Fetal Bovine Serum Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Fetal Bovine Serum Market  By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Charcoal Stripped
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Chromatographic
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Dialyzed Fetal Bovine Serum
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Exosome Depleted
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Stem Cell
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Other Products
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Fetal Bovine Serum Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Biopharmaceuticals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cell Culture Media
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Human and Animal Vaccine Production
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Drug Discovery
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Vaccine Production
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Fetal Bovine Serum Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Biotechnology and Pharmaceutical Industries
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Academic institutes
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Research labs
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Diagnostic labs
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. CROs
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. CMOs
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. IVF Centers
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
7.8. Others
7.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.8.3. Market Opportunity Analysis 
8.Global Fetal Bovine Serum Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Fetal Bovine Serum Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Charcoal Stripped
9.1.2.Chromatographic
9.1.3.Dialyzed Fetal Bovine Serum
9.1.4.Exosome Depleted
9.1.5.Stem Cell
9.1.6.Other Products
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Biopharmaceuticals
9.2.2.Cell Culture Media
9.2.3.Human and Animal Vaccine Production
9.2.4.Drug Discovery
9.2.5.Vaccine Production
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Biotechnology and Pharmaceutical Industries
9.3.2.Academic institutes
9.3.3.Research labs
9.3.4.Diagnostic labs
9.3.5.CROs
9.3.6.CMOs
9.3.7.IVF Centers
9.3.8.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Fetal Bovine Serum Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Charcoal Stripped
10.1.2.Chromatographic
10.1.3.Dialyzed Fetal Bovine Serum
10.1.4.Exosome Depleted
10.1.5.Stem Cell
10.1.6.Other Products
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Biopharmaceuticals
10.2.2.Cell Culture Media
10.2.3.Human and Animal Vaccine Production
10.2.4.Drug Discovery
10.2.5.Vaccine Production
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Biotechnology and Pharmaceutical Industries
10.3.2.Academic institutes
10.3.3.Research labs
10.3.4.Diagnostic labs
10.3.5.CROs
10.3.6.CMOs
10.3.7.IVF Centers
10.3.8.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Fetal Bovine Serum Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Charcoal Stripped
11.1.2.Chromatographic
11.1.3.Dialyzed Fetal Bovine Serum
11.1.4.Exosome Depleted
11.1.5.Stem Cell
11.1.6.Other Products
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Biopharmaceuticals
11.2.2.Cell Culture Media
11.2.3.Human and Animal Vaccine Production
11.2.4.Drug Discovery
11.2.5.Vaccine Production
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Biotechnology and Pharmaceutical Industries
11.3.2.Academic institutes
11.3.3.Research labs
11.3.4.Diagnostic labs
11.3.5.CROs
11.3.6.CMOs
11.3.7.IVF Centers
11.3.8.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Fetal Bovine Serum Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Charcoal Stripped
12.1.2.Chromatographic
12.1.3.Dialyzed Fetal Bovine Serum
12.1.4.Exosome Depleted
12.1.5.Stem Cell
12.1.6.Other Products
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Biopharmaceuticals
12.2.2.Cell Culture Media
12.2.3.Human and Animal Vaccine Production
12.2.4.Drug Discovery
12.2.5.Vaccine Production
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Biotechnology and Pharmaceutical Industries
12.3.2.Academic institutes
12.3.3.Research labs
12.3.4.Diagnostic labs
12.3.5.CROs
12.3.6.CMOs
12.3.7.IVF Centers
12.3.8.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Fetal Bovine Serum Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Charcoal Stripped
13.1.2.Chromatographic
13.1.3.Dialyzed Fetal Bovine Serum
13.1.4.Exosome Depleted
13.1.5.Stem Cell
13.1.6.Other Products
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Biopharmaceuticals
13.2.2.Cell Culture Media
13.2.3.Human and Animal Vaccine Production
13.2.4.Drug Discovery
13.2.5.Vaccine Production
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Biotechnology and Pharmaceutical Industries
13.3.2.Academic institutes
13.3.3.Research labs
13.3.4.Diagnostic labs
13.3.5.CROs
13.3.6.CMOs
13.3.7.IVF Centers
13.3.8.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Thermo Fischer Scientific, Inc.
14.2.2.Danaher Corporation
14.2.3.Merck KGaA
14.2.4.HiMedia Laboratories
14.2.5.GE Healthcare
14.2.6.PAN-Biotech
14.2.7.Rocky Mountain Biologicals
14.2.8.BioWest
14.2.9.TCS Biosciences Ltd
14.2.10.Atlas Biologicals
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Thermo Fischer Scientific, Inc.
  • Danaher Corporation
  • Merck KGaA
  • HiMedia Laboratories
  • GE Healthcare
  • PAN-Biotech
  • Rocky Mountain Biologicals
  • BioWest
  • TCS Biosciences Ltd
  • Atlas Biologicals

Related Industry Reports